Are you Dr. Alavi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-3914Fax+1 215-615-3380
Summary
- Dr. Jane Alavi, MD is a hematologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1969 - 1971
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1968 - 1969
University of Virginia Medical CenterResidency, Internal Medicine, 1967 - 1968- University of Virginia Medical CenterInternship, Transitional Year, 1966 - 1967
Harvard Medical SchoolClass of 1966
Certifications & Licensure
PA State Medical License 1971 - 2021
Clinical Trials
- Gene Therapy in Treating Patients With Primary Brain Tumors Start of enrollment: 1996 Feb 01
Publications & Presentations
PubMed
- Abass Alavi. A distinguished physician scientist and a pioneer in molecular imaging.Abass Alavi, Mateen Moghbel, Jane B. Alavi
Hellenic Journal of Nuclear Medicine. 2014-05-01 - 17 citationsPhase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas.Michelle A. Rudek, Pamela New, Tom Mikkelsen, Surasak Phuphanich, Jane B. Alavi
Journal of Neuro-Oncology. 2011-05-06 - 49 citationsMulti-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas.Casilda Balmaceda, David M. Peereboom, Susan C. Pannullo, Ying Kuen K. Cheung, Paul G. Fisher
Cancer. 2008-03-01
Grant Support
- Upcc8399: Oral Procarbazine In Treatment Of Recurrent High Grade AstrocytomaNational Center For Research Resources2000–2002
- Upcc7399: Pyrazolacridine In Adults W Newly Diagnosed Glioblastoma MultiformeNational Center For Research Resources2000–2002
- Pre-Irradiation 9-Amino-20(S)-Camptothecin In GlioblastoNational Center For Research Resources2000–2002
- Continuous Exposure Oral Phenylbutyrate 3 Time Daily ScheduleNational Center For Research Resources1999–2002
- New Approaches To Brain Tumor Therapy--A CNS ConsortiumNational Cancer Institute2001
- Phase 1 Trial Of Hsvtk Gene Therapy For CNS TumorsNational Center For Research Resources1999–2000
- Phase I Evaluation Of Phenylbutyrate In GliomaNational Center For Research Resources1998–1999
- Phase 1 Trial Of Hsvtr Gene Therapy For CNS TumorsNational Center For Research Resources1997–1998
- Phase I Trial Of Hsvtk Gene Therapy For CNS TumorsNational Cancer Institute1995–1997
